EPIQ Capital Group’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-86,291	Closed	-$224K	–	80
2024 Q3	$224K	Hold	86,291	–	–	0.06%	64
2024 Q2	$255K	Hold	86,291	–	–	0.09%	54
2024 Q1	$391K	Hold	86,291	–	–	0.16%	39
2023 Q4	$493K	Hold	86,291	–	–	0.23%	29
2023 Q3	$397K	Hold	86,291	–	–	0.22%	34
2023 Q2	$557K	Hold	86,291	–	–	0.3%	27
2023 Q1	$651K	Hold	86,291	–	–	0.34%	23
2022 Q4	$874K	Hold	86,291	–	–	0.5%	19
2022 Q3	$853K	Sell	86,291 -23,756	-22%	-$261K	0.45%	20
2022 Q2	$1.17M	Buy	110,047 +18,847	+21%	+$160K	0.49%	21
2022 Q1	$889K	Sell	91,200 -1,158	-1%	-$11K	0.24%	25
2021 Q4	$1.32M	Sell	92,358 -50,612	-35%	-$768K	0.23%	24
2021 Q3	$2.87M	Buy	+142,970	New	+$2.53M	0.3%	16